HEIDELBERG PHARMA AG O.N./ DE000A11QVV0 /
11/09/2024 20:01:05 | Chg. -0.060 | Volume | Bid11/09/2024 | Ask11/09/2024 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
2.320EUR | -2.52% | - Turnover: - |
2.320Bid Size: 907 | 2.530Ask Size: 830 | 84.07 mill.EUR | 0.00% | - |
Assets
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 1.3000 | 1.1000 | 1 | 1.3000 | 1.3000 | ||||||
Intangible Assets | 3.1000 | 2.9000 | 2.9000 | 2.8000 | 2.8000 | ||||||
Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Fixed Assets | 12.8000 | 12.1000 | 10 | 10.3000 | 10.3000 | ||||||
Inventories | .0800 | .2000 | .3000 | .2000 | .2000 | ||||||
Accounts Receivable | .2000 | .2000 | .4000 | .0900 | .3000 | ||||||
Cash and Cash Equivalents | 8.9000 | 2.2000 | 1.3000 | 4.6000 | 30.4000 | ||||||
Current Assets | 9.5000 | 2.9000 | 2.1000 | 5 | 31.2000 | ||||||
Total Assets | 22.3000 | 15 | 12.1000 | 15.2000 | 41.5000 |
Liabilities
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | .2000 | .3000 | .3000 | .1000 | 1.5000 | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | 2.6000 | 0.0000 | 0.0000 | 3.7000 | 0.0000 | ||||||
Provisions | - | - | - | .4000 | .4000 | ||||||
Liabilities | 7.3000 | 3.2000 | 2.6000 | 5.5000 | 4.5000 | ||||||
Share Capital | 7.8250 | 7.8190 | 9.3060 | 12.9280 | 22.4530 | ||||||
Total Equity | 14.9000 | 11.9000 | 9.5000 | 9.8000 | 37 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 22.3000 | 15 | 12.1000 | 15.2000 | 41.5000 |
Income Statement
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 19.1000 | 5 | 3.9000 | 2.7000 | 1.9000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | -5 | -5.6000 | -6.5000 | -6.4000 | -10.8000 | ||||||
Interest Income | -.0800 | -.0300 | .0030 | -.0190 | -.2000 | ||||||
Income Before Taxes | -5 | -5.6000 | -6.5000 | -6.4000 | -11 | ||||||
Income Taxes | 0.0000 | .0900 | .0400 | 0.0000 | 0.0000 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Net Income | -5 | -5.7000 | -6.6000 | -6.4000 | -11 |
Per Share
Cash Flow
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -14.5000 | -6.6000 | -4.8000 | -6.5000 | -7.9000 | ||||||
Cash Flow from Investing Activities | -.2000 | -.2000 | -.2000 | -.5000 | -.4000 | ||||||
Cash Flow from Financing | -.2000 | -.0400 | 4.1000 | 10.3000 | 34.2000 | ||||||
Decrease / Increase in Cash | -14.4000 | -6.7000 | -.9000 | 3.3000 | 25.8000 | ||||||
Employees | 92 | 52 | 55 | 53 | 58 |